Sign Up
HB 1033 North Dakota House · 67th Legislative Assembly (2021-2022)

Relating to prescribing of biosimilar drugs.

Bill status signed all 5 stages cleared
Introduction
Jan 2021
Committee Review
Mar 2021
House Passage
Apr 2021
Senate Passage
Mar 2021
Signed into Law
Apr 2021
Introduced Jan 5, 2021 Signed Apr 20, 2021
Floor votes · Senate Mar 22, 2021 · House Apr 13, 2021

How they voted

47–0
Passed
Total votes 47
Mar 22, 2021
D Democratic7
7 Yea
100% Yea
R Republican40
40 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
19
Key actions
11
Committee
4
Apr 21, 2021
Introduced
Filed with Secretary Of State 04/20
legislature
Apr 20, 2021
Signed into law
Signed by Governor 04/19
executive
Apr 13, 2021
Lower · Passed
Second reading, passed, yeas 94 nays 0
lower
Apr 13, 2021
Lower · Passed
Concurred
lower
Mar 22, 2021
Upper · Passed
Second reading, passed as amended, yeas 47 nays 0
upper
Mar 19, 2021
Upper · Passed
Amendment adopted, placed on calendar
upper
Mar 17, 2021
Upper · Passed
Reported back amended, do pass, amendment placed on calendar 6 0 0
upper
Mar 10, 2021
Upper · Passed
Committee Hearing 02:30
upper
Mar 3, 2021
Introduced
Introduced, first reading, referred Human Services Committee
upper
Feb 23, 2021
Lower · Passed
Second reading, passed, yeas 92 nays 1
lower
Feb 15, 2021
Lower · Passed
Amendment adopted, placed on calendar
lower
Feb 12, 2021
Lower · Passed
Reported back amended, do pass, amendment placed on calendar 13 1 0
lower
Jan 6, 2021
Lower · Passed
Committee Hearing 10:45
lower
Jan 5, 2021
Introduced
Introduced, first reading, referred Human Services Committee
lower
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.